Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors by E. V. Artamonova, E. I. Kovalenko

Get full text

Efficiency and tolerability of abemaciclib in elderly patients by E. I. Kovalenko, M. V. Khoroshilov, E. V. Artamonova

Get full text

Kapetsitabin v terapiiantratsiklin- i taksanrezistentnogoraka molochnoy zhelezy by E I Kovalenko, E V Artamonova, E F Satirova, L V Manzyuk

Get full text

Adverse effects of adjuvant endocrine therapy by E. I. Kovalenko, I. B. Kononenko, A. V. Snegovoi, O. P. Grebennikova, L. V. Manzyuk

Get full text

Tactics for minimizing risk of increasing estradiol against the background of aromatase inhibitors in combination with gonadotropin releasing hormone agonists in adjuvant therapy f... by I. B. Kononenko, A. V. Snegovoi, L. V. Manzyuk, E. I. Kovalenko, V. Yu. Selchuk

Get full text

Importance of evaluation of ovarian function in women with breast cancer when using endocrinotherapy by I. B. Kononenko, A. V. Snegovoi, E. I. Kovalenko, L. V. Manzyuk, V. Yu. Selchuk

Get full text

NK cells expansion <i>in vitro</i> is followed by loss of inhibitory KIR expression by N. A. Alekseeva, M. O. Ustyuzhanina, M. A. Streltsova, M. V. Grechikhina, G. V. Lutsenko, E. I. Kovalenko

Get full text

CDK4/6 inhibitors in the treatment of metastatic breast cancer. Choosing optimal therapy for estrogen-receptor-positive HER2-negative metastatic breast cancer: analysis of doctors’... by E. V. Artamonova, E. I. Kovalenko, L. V. Bolotina, M. B. Stenina, R. V. Orlova, M. A. Mukhina

Get full text

Coordination of NK cell markers expression and IgG response in hCMV infection by M. O. Ustiuzhanina, Ju. D. Vavilova, N. A. Alekseeva, G. V. Lutcenko, D. M. Chudakov, E. I. Kovalenko

Get full text

DISTRIBUTION OF <i>MICA</i> ALLELES IN THE RUSSIAN POPULATION by L. M. Kanevskiy, M. V. Grechikhina, E. G. Kuzmina, T. Yu. Mushkarina, A. A. Spelkov, M. A. Streltsova, E. I. Kovalenko

Get full text

CIRCULATING MICA PROTEIN IN PATIENTS WITH MALIGNANT LYMPHOMAS by A. V. Klinkova, E. G. Kuzmina, E. V. Abakushina, L. M. Kanevskiy, G. S. Neprina, V. V. Pavlov, E. I. Kovalenko

Get full text

Analysis of the association of the polymorphism of the CLIC1, MSH5, C6orf26, C6orf25 genes with the expression level of the HSPA1B gene by Yu. D. Vavilovа, A. A. Boyko, E. I. Kovalenko, M. V. Grechikhina, O. A. Shustova, T. L. Azhikina, A. M. Sapozhnikov

Get full text

Clinical significance of changes in the expression level of markers of surrogate breast cancer subtypes in recurrent and metastatic foci (literature review) by Yu. S. Krumin, V. A. Khaylenko, N. A. Kozlov, G. Yu. Cheremis, A. V. Petrovskyy, D. V. Khaylenko, E. V. Artamonova, E. I. Kovalenko

Get full text

Umbilical cord blood as a promising source of NK cells for immunotherapy by R. A. Velichinskii, J. D. Vavilova, A. A. Boyko, O. A. Shustova, A. I. Palamarchuk, G. M. Yusubalieva, O. N. Kucherova, M. A. Streltsova, E. I. Kovalenko

Get full text

TREATMENT OF BREAST CANCER WITH METASTATIC CONTRALATERAL AXILLARY LYMPH NODES: CASE REPORT AND LITERATURE REVIEW by V. A. Amosova, A. V. Petrovsky, M. V. Chernykh, E. I. Kovalenko, M. A. Frolova, R. K. Valiev, M. I. Nechushkin, V. U. Kirsanov, I. V. Vysotskaya, D. E. Avtomonov

Get full text

Microenvironment-related predictive markers of the therapeutic effectiveness of eribulin in patients with locally advanced or metastatic breast cancer: pilot study by L.  A. Tashireva, N. O. Popova, V. V. Alifanov, V. E.  Goldberg, E. I. Kovalenko, E. V. Artamonova, A. G.  Manikhas, D. M. Ponomarenko, N. V. Levchenko, E. I. Rossokha, S. Yu.  Krasilnikova, M. A. Zafirova, V. M.  Perelmuter

Get full text

The results of the first retrospective data analysis of eribulin application in patients with metastatic breast cancer in actual clinical practice in Russia by L V Bolotina, L V Manziuk, V A Gorbunova, E I Kovalenko, G Z Mukhametshina, A I Khasanova, L Yu Vladimirova, I S Mitashok, E P Prokofyeva, I V Evstigneeva, I I Andreyashkina, N A Abramova, I L Popova, E V Karabina, A A Teterich, E A Gaysina, V A Chubenko, S V Limareva, N M Tikhanovskaya, A E Storozhakova, N Yu Samaneva, Ya V Svetitskaya, T A Snezhko, E A Kalabanova

Get full text

The improvement in overall survival for patients with metastatic breast cancer treated with eribulin: the resolution based on results of the expert council by V S Andrianova, A V Beliaeva, L V Bolotina, A A Vazhenina, S E Varlamova, V I Vladimirov, L Yu Vladimirova, E K Voznyi, S M Demidov, N V Zhukov, L G Zhukova, E N Imianitov, E I Kovalenko, L M Kogoniia, M M Konstantinova, S A Lan, M R Lichinitser, L V Manziuk, A G Manikhas, G Z Mukhametshina, V F Semiglazov, T Iu Semiglazova, G V Seregina, D L Stroiakovskii, M D Ter-Ovanesov, A S Chichkanova

Get full text

Eribulin-trastuzumab combination in HER2-positive metastatic breast cancer: updated results from a Russian observational study by E. I. Kovalenko, E. V. Artamonova, L. V. Bolotina, L. A. Zhiliaeva, D. M. Ponomarenko, E. V. Karabina, G. Z. Mukhametshina, A. I. Khasanova, E. Yu. Ratner, A. R. Safarova, A. G. Manikhas, N. O. Popova, I. V. Evstigneeva, L. Yu. Vladimirova, L. V. Kramskaya, T. V. Karandeeva, I. R. Suslova, O. V. Romanchuk, V. E. Shikina, A. Yu. Povyshev, M. A. Osipov, E. M. Cherniakova, A. S. Dergunov, M. V. Volkonskiy, I. S. Chernov, I. E. Shumskaya, M. M. Fael, V. I. Garifullina, I. E. Gudkova

Get full text